FindTrial
Sign In

Effects of goal-directed administration of ropivacaine and sufentanil in Epidural Labor Analgesia.

Effects of goal-directed administration of ropivacaine and sufentanil in Epidural Labor Analgesia.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016345
Enrollment
Unknown
Registered
2018-05-26
Start date
2018-05-24
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labor

Interventions

Group A:epidural background8ml/h 0.125%Ropivacaine+0.4ug/ml sufentanil in the first and second term
Group B:epidural background8-12ml/h 0.125%Ropivacaine+0.4ug/ml sufentanil in the first and second term
Group C:epidural background8ml/h 0.125%Ropivacaine+0.4ug/ml sufentanil in the first term and 8ml/h 0.8ug/ml sufentanil in the second term
Group D:epidural background8-12ml/h 0.125%Ropivacaine+0.4ug/ml sufentanil in the first term and 8-12ml/h 0.8ug/ml sufentanil in the second term

Sponsors

Maternity and Child Affiliated Hospital, Jiaxing University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to 40 Years

Inclusion criteria

Inclusion criteria: full-term nulliparous women

Exclusion criteria

Exclusion criteria: Significant medical or obstetric morbidity, history of allergy to Ropivacaine, contraindication for epidural aneshtesia

Design outcomes

Primary

MeasureTime frame
PCA;local anesthetic volum;VAS score;time of the first and second term;newborn blood gas analysis;—

Countries

China

Contacts

Public ContactChang'na Wei

Maternity and Child Affiliated Hospital, Jiaxing University

544631360@qq.com+86 18267382732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026